Search ( 1993 results )
- surveys/studies
(Updated on )
Nutri-Score: Changes in its awareness, perception, and impact on reported purchasing behavior between 2018 and 2020
In 2020, awareness of Nutri-Score continued to grow, reaching 93%. This increase is due to the gradual appearance of the logo on packaging; Nutri-Score is spontaneously cited by 18% of...
- surveys/studies
(Updated on )
Survival of People with Cancer in Metropolitan France, 1989–2018 - Chronic myeloproliferative syndromes other than chronic myeloid leukemia - Essential thrombocythemia
In France, for the year 2018, the estimated number of new cases of TE was 2,057, including 862 in men and 1,195 in women. Key points: Standardized net survival of 99% at 1 year and 91%...
- surveys/studies
(Updated on )
Exposure of the French population to metals in urine. National Biomonitoring Program. Esteban 2014–2016.
Urinary levels of 27 metal elements were measured as part of the Esteban study. Following consultation with the scientific advisory board, it was decided to conduct a descriptive...
- surveys/studies
(Updated on )
Mercury Exposure in the French Population. National Biomonitoring Program, Esteban 2014–2016
Mercury is toxic to humans; its effects depend on its chemical form, the route of exposure, the timing and duration of exposure, and the dose absorbed. Mercury is not only harmful to the...
- surveys/studies
(Updated on )
Survival of Cancer Patients in Metropolitan France, 1989–2018 – Lung, Adenocarcinoma
In France, in 2018, the estimated number of new cases of lung adenocarcinoma was 24,791, including 15,293 in men and 9,498 in women. Key points: The 5-year age-standardized net survival...
- surveys/studies
(Updated on )
Survival Rates for People with Cancer in Metropolitan France, 1989–2018 - Renal Parenchyma
In France, in 2018, the estimated number of new cases of renal parenchymal cancer was 13,323, 67% of which occurred in men. The estimated number of deaths was 5,589, 68% of which...
- surveys/studies
(Updated on )
Survival of Cancer Patients in Metropolitan France, 1989–2018 - Mature T/NK-cell Lymphoma
In France, in 2018, the estimated number of new cases of mature T/NK-cell lymphoma was 1,777, including 997 in men and 780 in women. Key points: A cancer with an intermediate prognosis,...
- surveys/studies
(Updated on )
Survival of Cancer Patients in Metropolitan France, 1989–2018 - Hypopharynx
In France, for the year 2018, the estimated number of new cases of hypopharyngeal cancer was 1,867 among men and 281 among women. Key points: 5-year age-standardized net survival of 26%...
- surveys/studies
(Updated on )
Survival Rates for People with Cancer in Metropolitan France, 1989–2018 - Hodgkin’s Lymphoma
In France, the estimated number of new cases of Hodgkin lymphoma in 2018 was 2,127, including 1,240 cases in men and 887 cases in women. Key points: A favorable prognosis, with a 5-year...
- surveys/studies
(Updated on )
Survival of People with Cancer in Metropolitan France, 1989–2018 - Diffuse Large B-Cell Lymphoma
In France, for the year 2018, the estimated number of new cases of diffuse large B-cell lymphoma was 5,071, including 2,778 in men and 2,293 in women. Key points: 5-year age-adjusted...